Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterol­aemia: TULiPS (Turkish Lipid Study)

Abstract

This open-label study indicates fluvastatin XL 80 mg once daily is an effective and well-tolerated lipid-lowering therapy for the reduction of CHD risk in Turkish patients.

Radial Artery Catheterization for Percutaneous Vascular or Coronary Interventions: An Innocent Procedure?

“…[28][29][30] Statins reduce CRP levels. [31][32][33] C-reactive protein levels may be used to assess the effect of statins on arterial damage caused by catheterization.…”

C-reactive protein (CRP): more than just an innocent bystander?

“…Following lower extremity bypass operations, elevated CRP levels are associated with an increased risk of graft occlusion and postoperative e v e n t s 2 3-2 5 . I n p a t i e n t s u n d e r g o i n g c a r o t i d 40 , statins (atorvastatin [41][42][43][44] , rosuvastatin 35,41,42 , fluvastatin 45 and pravastatin 46 ), fenofibrate 43,44,47 and ciprofibrate 48,49 . The mechanisms by which these drugs lower CRP levels are more extensively reviewed elsewhere 50 .…”

Short Term Fluvastatin Treatment Lowers Serum Asymmetric Dimethylarginine Levels in Patients With Metabolic Syndrome

“…14,28) The 39% decrease in LDL cholesterol among patients receiving fluvastatin in the present study seems to be consistent with the findings of previous statin studies conducted in hypercholesterolemia or MetS patients. 29,30) MetS is a chronic inflammatory cardiovascular condition and CRP levels are known to be high among MetS patients. 31,32) Statin treatments have been shown to decrease hs-CRP levels, which is an inflammatory marker accepted as an important cardiovascular risk factor for coronary and MetS patients.…”